pubrio
Vaxxas

Vaxxas

Australia · Research

Research

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will help the world in rethinking what's possible with vaccines.

Company Insights
Company Overview

2011

Founded

Research

Industry

Australia

Location

1,239,418

Ranking

200 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Vaxxas

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​